№ lp_1_2_44142
File format: docx
Character count: 12392
File size: 146 KB
This document provides regulatory information for health practitioners about the use, storage, and supply of Schedule 2 and 3 poisons (OTC medicines) under Victorian law, emphasizing the legal requirements for administering, prescribing, and supplying these substances.
Year:
2021
Region / City:
Victoria, Australia
Theme:
Medicine regulation, poisons schedules
Document type:
Official regulatory guidance
Organization / Institution:
Medicines and Poisons Regulation
Author:
Medicines and Poisons Regulation
Target audience:
Health practitioners, pharmacists, medical professionals
Period of validity:
Indefinite
Date of approval:
2017
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022-2023
Region / City:
Ozarks
Subject:
Education, Degree Program
Document Type:
Academic Guide
Organization / Institution:
Ozarks Technical Community College, Missouri State University
Author:
N/A
Target Audience:
Students pursuing a degree in Journalism
Period of Validity:
Catalog Year 2022-2023
Approval Date:
N/A
Date of Changes:
4.19.22
Year:
2023
Region / City:
Australia
Theme:
Supervision, Occupational Therapy
Document Type:
Log/Report
Institution:
Ahpra
Author:
Unknown
Target Audience:
Supervisors, Practitioners
Action Period:
Ongoing (as supervision sessions occur)
Approval Date:
Unknown
Modification Date:
Unknown
Year:
2012
Region / city:
EU
Theme:
Regulation, OTC Derivatives, CCPs
Document Type:
Consultation Response
Organization / Institution:
ESMA
Author:
Triple Point Technology Inc.
Target Audience:
ESMA, market participants, regulatory bodies
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2019
Region / City:
Australia
Theme:
Financial regulation, Product intervention, Retail clients, OTC derivatives
Document Type:
Consultation paper
Organization / Institution:
Australian Securities and Investments Commission (ASIC)
Author:
Australian Securities and Investments Commission
Target Audience:
Retail clients, Product issuers, Stakeholders in financial regulation
Effective Period:
From 22 August 2019 onwards
Approval Date:
22 August 2019
Amendment Date:
None
Year:
2016
Region / City:
Hong Kong
Topic:
OTC Derivatives Regulation
Document Type:
Consultation Paper
Regulatory Body:
Hong Kong Monetary Authority (HKMA), Securities and Futures Commission (SFC)
Author:
Hong Kong Monetary Authority (HKMA), Securities and Futures Commission (SFC)
Target Audience:
Financial Institutions, OTC Derivatives Market Participants
Effective Period:
February 2016 - Ongoing
Approval Date:
February 2016
Amendment Date:
Not specified
Year:
2026
Region / city:
Victoria, Australia
Subject:
Pharmaceutical regulations
Document type:
Legislative guideline
Institution:
Medicines and Poisons Regulation
Author:
Medicines and Poisons Regulation
Target audience:
Pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of changes:
None specified
Year:
2025-2026
Region / city:
Australia
Subject:
Fines and penalties related to the administration of the Drugs, Poisons and Controlled Substances Act 1981
Document type:
Official publication
Organ / institution:
Minister for Health
Author:
Not specified
Target audience:
General public
Period of validity:
2025-2026
Approval date:
Not specified
Amendment date:
Not specified
Year:
2023
Region:
Victoria, Australia
Subject:
Regulation of drugs, poisons, and controlled substances
Document type:
Legal code
Legislative basis:
Drugs, Poisons and Controlled Substances Act 1981, Sections 12 and 12E
Author:
Mary-Anne Thomas, Minister for Health
Date of publication:
23 January 2023
Effective date:
1 February 2023
Website:
https://www.health.vic.gov.au/drugs-and-poisons/poisons-code
Jurisdiction:
Australian Capital Territory
Instrument number:
NI2021-161
Type of instrument:
Notifiable instrument
Legislation:
Medicines, Poisons and Therapeutic Goods Regulation 2008
Relevant Act:
Medicines, Poisons and Therapeutic Goods Act 2008
Made under:
Section 575 (Controlled medicines prescribing standards)
Date made:
31 March 2021
Commencement:
Day after notification day
Revokes:
Medicines, Poisons and Therapeutic Goods (Category Approval) Determination 2021 (No 1) – NI2021-39
Issuing authority:
Chief Health Officer
Name of signatory:
Dr Kerryn Coleman
Administering body:
Health Protection Service
Subject matter:
Prescribing of controlled medicines
Geographical scope:
Australian Capital Territory
Contact:
[email protected]
Note:
; 5124 9700
Year:
2021
Region / City:
Australian Capital Territory
Topic:
Medicines, poisons, therapeutic goods regulation
Document Type:
Regulation
Authority / Institution:
Australian Government
Author:
Australian Capital Territory Government
Target Audience:
Health professionals, regulators, and relevant stakeholders
Period of Effect:
Ongoing
Approval Date:
2021
Amendment Date:
N/A
Year:
2018
Region / City:
Australian Capital Territory
Topic:
Controlled Medicines Prescribing Standards
Document Type:
Regulatory Instrument
Authority / Organization:
Chief Health Officer
Author:
Dr Paul Kelly
Target Audience:
Prescribers of controlled medicines
Period of validity:
Ongoing
Approval Date:
26 September 2018
Date of Changes:
N/A
Year:
2020
Region / City:
Australian Capital Territory
Topic:
Health Regulation
Document Type:
Amendment Regulation
Authority:
Australian Government
Author:
Australian Government
Target Audience:
Medical Radiation Practitioners, Healthcare Professionals
Period of Effect:
From the day after notification
Approval Date:
Not specified
Amendment Date:
2020
Changes:
Amendment to the Medicines, Poisons and Therapeutic Goods Regulation 2008
Description:
The document outlines the amendment to the Medicines, Poisons and Therapeutic Goods Regulation 2008, authorising medical radiation practitioners to deal with scheduled medicines within their professional scope of practice.
Year:
2025
Region / City:
Australian Capital Territory
Topic:
Medicines and Poisons Regulation
Document Type:
Legislation
Authority:
Australian Government
Author:
Australian Capital Territory Government
Target Audience:
Health professionals, regulatory authorities, medical practitioners
Effective Period:
From 2025 onwards
Approval Date:
2025
Amendment Date:
2025
Contextual Description:
Legislative text outlining amendments to the Medicines, Poisons and Therapeutic Goods Regulation 2008 in the Australian Capital Territory, specifically regarding controlled medicines and emergency medical supplies.
Year:
1964
Region / city:
Western Australia
Theme:
Pharmacy regulations, poisons management
Document type:
Application form
Authority / institution:
Department of Health, Western Australia
Author:
Pharmaceutical Services Branch
Target audience:
Pharmacy licence applicants
Effective period:
Ongoing
Approval date:
Not specified
Amendment date:
Not specified
Year:
2014
Region / City:
Australia
Topic:
Medicines and Poisons Regulations
Document Type:
Application Form
Organization / Institution:
Department of Health
Author:
Unknown
Target Audience:
Individuals and entities applying for a Schedule 2 Retail Licence
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2016
Region / City:
Western Australia, AU
Topic:
Health / Hospital practice / Medication management
Document Type:
Regulatory guidance / Professional practice document
Institution:
Department of Health, Western Australia
Target Audience:
Anaesthetic technicians, hospital staff
Scope of Practice:
Administration, possession, and storage of S4 and S8 medicines under direction of anaesthetist
Record Keeping:
Clinical records retention for S4 (2 years) and S8 (5 years), monthly inventory for S8 medicines
Compliance:
Routine audit assessments and adherence to Medicines and Poisons Regulations 2016
Contact Information:
Medicines and Poisons Regulation Branch, [email protected]
Note:
, (08) 9222 6883
Jurisdiction:
Western Australia
Legislation:
Medicines and Poisons Regulations 2016
Regulatory Authority:
Department of Health
Professional Regulator:
Nursing and Midwifery Board of Australia
Subject:
Authority to obtain, possess, administer, supply and prescribe medicines
Applicable Professions:
Nurse Practitioner; Registered Nurse; Enrolled Nurse; Endorsed Midwife; Midwife
Medicine Schedules:
Schedule 4 (S4); Schedule 8 (S8)
Scope of Application:
Lawful professional practice within defined scope and conditions
Requirements:
Storage, recording, inventory control, and compliance assessment obligations
Record Retention Period:
Minimum 2 years for S4 medicines; minimum 5 years for S8 medicines
Compliance Measures:
Audit assessments and regulatory enforcement provisions
Contact Body:
Medicines and Poisons Regulation Branch
Year:
2024
Jurisdiction:
Australia
Subject:
Regulation of poisons and controlled substances
Document type:
Legal instrument
Issuing authority:
Department of Health and Aged Care
Author:
Sarah Syme, Assistant Secretary Regulatory Engagement Branch
Effective date:
27 September 2024
Amendments:
Not indicated
Scope:
Human and veterinary medicines, hazardous substances
Classification system:
Schedules 1–10, Appendices A–L
Target audience:
Healthcare professionals, pharmacists, regulatory bodies
Year:
2016
Region:
Australia / Western Australia
Subject:
Pharmacy practice, Medicines regulation
Document type:
Regulatory guidance
Institution:
Department of Health, Western Australia
Author:
Medicines and Poisons Regulation Branch
Target audience:
Registered pharmacists
Scope of authority:
Purchase, possess, administer, supply, dispense, prescribe medicines
Storage requirements:
Locked storage for S4 and purpose-built safes for S8 medicines
Record-keeping:
Clinical and transaction records retention (S4 – 2 years, S8 – 5 years)
Compliance monitoring:
Routine audits and regulatory enforcement
Contact information:
[email protected], (08) 9222 6883
Year:
Not specified
Region / city:
Australia
Subject:
Registration of overseas qualified Chinese medicine practitioners
Document type:
Information leaflet
Institution:
Chinese Medicine Board of Australia (CMB)
Author:
Not specified
Target audience:
Internationally qualified Chinese medicine practitioners
Validity period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified